Yayın:
Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKAYA TİLKİ, ELİF
dc.contributor.authorCANTÜRK, ZERRİN
dc.contributor.authorDikmen, Miriş
dc.contributor.authorMiriş Dikmen
dc.contributor.orcid0000-0003-1534-8117
dc.contributor.orcid0000-0003-2122-5324
dc.contributor.orcid0000-0001-7709-4285
dc.contributor.orcid0009-0000-1090-0166
dc.date.accessioned2025-11-13T11:13:32Z
dc.date.issued2024-05-22
dc.identifier.doihttps://doi.org/10.1111/apm.13426
dc.identifier.endpage607
dc.identifier.issn0903-4641
dc.identifier.issue8
dc.identifier.openalexW4398222300
dc.identifier.startpage594
dc.identifier.urihttps://hdl.handle.net/11421/6102
dc.identifier.urihttps://doi.org/10.1111/apm.13426
dc.identifier.volume132
dc.language.isoen
dc.relation.ispartofApmis
dc.rightsopenAccess
dc.subjectAngiogenesis
dc.subjectIxazomib
dc.subjectBortezomib
dc.subjectCancer research
dc.subjectProteasome inhibitor
dc.subjectA549 cell
dc.subjectUmbilical vein
dc.subjectMetastasis
dc.subjectCancer cell
dc.subjectNeovascularization
dc.subjectDownregulation and upregulation
dc.subjectMedicine
dc.subjectBiology
dc.subjectCancer
dc.subjectImmunology
dc.subjectLung cancer
dc.subjectMultiple myeloma
dc.subjectIn vitro
dc.subjectPathology
dc.subjectInternal medicine
dc.subjectCarfilzomib
dc.subjectGene
dc.subject.sdg3
dc.titleEnhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019197599
local.authorid.openalexA5085224535
local.authorid.openalexA5042645402

Dosyalar

Koleksiyonlar

Publications